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doi:10.1016/j.ejvs.2010.11.030Abstract Introduction: Since their introduction, biological glues have beenmore often used in
cardiac and vascular surgery in order to control bleeding and reinforce surgical anastomotic sites.
Report: Wereport a caseof a 54-year-oldwomandiagnosedwithacute limb ischaemiadue toem-
bolisation of biological glue, 45 days after her surgery for ascending aortic dissection. Her
ischaemia was successfully relieved by an urgent thrombectomy.
Discussion: Complications due to the use of biological glues remain rare but are very serious.
Preventive measures and intra-operative precautions must be considered in order to avoid most
of these complications.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Despite the important advancement in diagnosing and
managing type A aortic dissection, this condition remains
a challenge to the surgeon. To control intra- and post-
operative bleeding, anastomotic sites are sought to be
reconstructed and reinforced. Several techniques have
been applied, including the use of biological glues, in
sealing the dissected layers.
Since 1977, many types of glues have been introduced,
including gelatine-resorcinol-formaldehyde (GRF) glue,
Fibringlue and, most recently, Bioglue.11 3774018.
em@hotmail.com (M. Abi
ty for Vascular Surgery. PublisheComplications of biological glue usage have pointed to
the risk of aortic wall necrosis, redissection and glue
particle embolisation.2,3
Case Presentation
A 54-year-old woman awaiting surgery for an 8-cm
ascending aortic aneurysm was presented to the emergency
room with severe chest pain and hypotension, and was
diagnosed with an acute type A aortic dissection necessi-
tating an urgent Bentall procedure.
This was an acute dissection of a large aneurysm with
very thin tissue and the dissection involved the coronary
arteries. Technically, it was very complicated and requiredd by Elsevier Ltd. All rights reserved.
Figure 2 Bioglue fragments sent for pathology with size
ranging from 2 to 12 mm.
Acute Limb Ischemia Due to Embolisation 519the use of Bioglue. We used seven syringes of Bioglue
(5 ml each) during the procedure to reinforce the anasto-
motic sites. Three syringes were used between the layers
and four externally.
The patient did very well and was discharged on Cou-
madin (Warfarin) on postoperative day 5.
Five weeks later, the patient started complaining of
cold, pain and paraesthesia in her right leg, and presented
to the emergency room.
In the emergency room, the patient was afebrile,
hemodynamically stable and had a normal electrocardio-
gram (ECG). On physical examination, she did not have
a palpable femoral pulse on the right side. Her leg was
ischaemic but viable. Her international normalised ratio
(INR) was within normal range.
An urgent duplex ultrasound of the lower limb showed
a complete occlusion of the right common iliac artery.
Thus, an arterial thrombectomy was performed on an
emergency basis via the right common femoral artery, and
we were able to re-establish a normal arterial flow after
removal of gelatinous material. Pathological analysis of
those pieces revealed consolidated Bioglue (Figs. 1 and 2).
The patient recovered uneventfully without any post-
ischaemic sequelae. Her echocardiogram and computed
tomography (CT) scan of her chest show good function of
her aortic valve and no evidence of redissection.
Discussion
Bioglue is an adhesive solution approved by the Food and
Drug Administration (FDA) for use in the United States
under the Humanitarian Device Exemption (HDE) regula-
tions for the treatment of acute thoracic aortic dissections.
It is composed of purified bovine serum albumin (45%) and
glutaraldehyde (10%).
The mechanism of action for Bioglue is based on the
chemical reaction between aldehydes and amines. The
amines for this reaction are provided by the 3-amino groups
of lysine residues in albumin and extracellular matrix
proteins from the tissues. Glutaraldehyde, which is
a bifunctional aldehyde, serves as a bridge between
albumin molecules and binds albumin to tissue proteins.
Thus, this reaction forms a permanent covalent bondFigure 1 Bioglue fragments recovered after right lower
limb arterial thrombectomy.between the tissues and the adhesive. Linkage starts within
20e30 s and reaches maximum bonding capability in 3 min.
The solution can be used to attach the false lumen
during repair of an aortic dissection, and can be applied
externally to guard against any possible leaks during
repair.4
Suboptimal reconstruction of a fragile aortic wall may
lead to postoperative bleeding or secondary anastomosis
dehiscence. Several techniques of reinforcement have
been described, including the use of Teflon felt stripes or
biological glue to seal the dissected layers.
The use of biological glue has been commonly reported
to improve outcome and reduce mortality from acute type
A aortic dissections. However, many recent reviews have
raised concerns about the high re-operation rate due to
aortic wall necrosis and redissection.1
The cause of aortic wall necrosis and redissection
remains controversial, but most of the reviews and reports
relate it to the use of GRF glue. High formaldehyde
concentration in GRF (37%) compared to lower glutaralde-
hyde concentration in Bioglue (10%) may partially explain
the differences in redissection incidence after the use of
these adhesives.1,5
Although GFR and Bioglue have a comparable tensile
strength, data from several studies support the hypothesis
that Bioglue exhibits less toxic properties and is more
biocompatible than the previously favoured GRF glue.
As far as we know, it is still not clear whether GRF and
Bioglue differ in the risk of embolisation. The reported
cases of embolisation following the use of biological glue in
the literature are few and far in between.
Embolisation of biological glue was first described in
1995 following an acute type A aortic dissection repair. It
was a post-mortem study of a 72-year-old patient who died
after surgical repair using GRF glue with microscopic
particles of polymerised glue found in an afferent vessel of
ischaemic cerebral and meningeal regions.2
In 2004, a case report of post-mortem finding revealed
a Bioglue embolism to right and left coronary arteries,
resulting in a fatal right ventricular infarction.3
Recently, two case reports from Barcelona described an
acute limb ischaemia due to embolism of biological glue
520 M. El Feghaly et al.following type A aortic dissection repair. Bioglue was used
in those two cases.6
The three possible mechanisms that may have led to
peripheral embolisation were:
(1) mobilisation of glue particles through stitch channels in
the diseased aortic wall;
(2) direct glue escape in the true lumen during application
of the adherent agent; and
(3) escape of glue through re-entries distal to site of use.
Mechanisms 1 and 2 seem unlikely to be the cause of the
mentioned embolisms in our patient.
Mechanism 3 is the most probable cause in the case
discussed. Due to its fluidity and translucent properties,
the Bioglue adhesive could have travelled from the false
lumen to the true one through distal re-entry sites.
Following fixation to the aortic endothelium, the
embolic material could have been set free by aortic
pulsatile flow.6
Therefore, precautions must be taken when planning to
use biological glue, including keeping the surgical field as
dry as possible, applying pressure between layers to help
the binding process and taking caution in handling Bioglue
(less sticky than GRF), as any inappropriate applied pres-
sure may end in spillage of this uncoloured substance.6
A small gauze inserted in the aortic lumen at the
moment of glue deployment would help avoid accidental
insertion into the true lumen. This is paramount in the
aortic arch where accidental spillage into the true lumen
would be very difficult to recover.
In other patients, inflating a Foley balloon catheter in
the true lumen 2 cm from the anastomotic margin has
created the same effect. Additionally, the pressure applied
by the balloon brings the inner layer close to the outer onewhile closing the false lumen and preventing glue leakage
into the true lumen through a distal re-entry site.
Despite these embolic events, the use of biological glue
has been a positive experience, resulting in lower inci-
dences of postoperative bleeding.1
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